News Posts List
Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic
03/19/2010
Proteomics and subsequent validation yielded two novel prognostic markers and survival models which improved prediction of OS in mRCC patients over commonly used risk models. Implementation of these models has the potential to improve current risk stratification, although prospective validation will still be necessary.
Secretary of State Sam Reed has kidney cancer
03/19/2010
Spokesman David Ammons said Wednesday that Reed was diagnosed last week. He has a malignant tumor on his left kidney, and surgeons will remove the entire kidney on Monday at Virginia Mason Medical Center in Seattle.
NICE leaves many patients with rarer forms of cancer without drugs
03/19/2010
The National Institute for Health and Clinical Excellence (NICE) is failing to follow its own guidance aimed at making live-extending treatments available on the NHS, leaving many patients with rarer forms of cancer without drugs that could prolong their lives, a campaign group has said.
Senators question $1 million pay for charity's CEO
03/18/2010
Senators are questioning high salaries and expensive travel bills for executives at the Boys & Girls Clubs of America, raising issues that could jeopardize millions in federal funding for the national charity.
[Ed. note: The Kidney Cancer Association is ranked as a 4-Star charity, the highest rating, by Charity Navigator, putting it ahead of much larger charities, such as the American Cancer Society.]
Betrayal of 20,000 cancer patients
03/18/2010
Rationing body rejects ten drugs (allowed in Europe) that could have extended lives. Is the practice of medicine in the USA headed down this same path?
Was fight for life worth it? Seven years of medical bills added up to $618,616
03/18/2010
Would I do it all again? Absolutely. I couldn't not do it again.
IMO-2055 (EMD 1201081), TLR9 Agonist
03/18/2010
A presentation entitled A phase 2 multicenter, randomized, open-label study of two dose levels of IMO-2055 in patients with metastatic or recurrent renal cell carcinoma was made at the Eighth International Kidney Cancer Symposium.
Glowing Dye Improves Cancer Removal in Kidney
03/17/2010
A new way to provide clear images of cancerous tumors in the kidney during surgery promises to help physicians preserve as much kidney function as possible while still removing all the malignant tissue a significant advance as doctors discover that saving as much healthy kidney tissue as possible is crucial for the future health of cancer patients.
Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network
03/16/2010
Xp11 translocation renal cell carcinoma (RCC) is an RCC subtype affecting 15% of RCC patients <45 years. We analyzed the benefit of targeted therapy [vascular endothelial growth factor receptor (VEGFR)-targeted agents and/or mammalian target of rapamycin (mTOR) inhibitors] in these patients.
Cancer widow 'sold false hope'
03/14/2010
Mr Jones asserts that the reduction or elimination of glucose in the diet and taking vitamin B17, together with a strict exercise regime, defeats cancer.
News Feed